BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19308990)

  • 1. The SUMO-E3 ligase PIAS3 targets pyruvate kinase M2.
    Spoden GA; Morandell D; Ehehalt D; Fiedler M; Jansen-Dürr P; Hermann M; Zwerschke W
    J Cell Biochem; 2009 May; 107(2):293-302. PubMed ID: 19308990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIAS3 enhances the transcriptional activity of HIF-1α by increasing its protein stability.
    Nakagawa K; Kohara T; Uehata Y; Miyakawa Y; Sato-Ueshima M; Okubo N; Asaka M; Takeda H; Kobayashi M
    Biochem Biophys Res Commun; 2016 Jan; 469(3):470-6. PubMed ID: 26697750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide destabilizes Pias3 and regulates sumoylation.
    Qu J; Liu GH; Wu K; Han P; Wang P; Li J; Zhang X; Chen C
    PLoS One; 2007 Oct; 2(10):e1085. PubMed ID: 17987106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein.
    Sundvall M; Korhonen A; Vaparanta K; Anckar J; Halkilahti K; Salah Z; Aqeilan RI; Palvimo JJ; Sistonen L; Elenius K
    J Biol Chem; 2012 Jun; 287(27):23216-26. PubMed ID: 22584572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM8 modulates STAT3 activity through negative regulation of PIAS3.
    Okumura F; Matsunaga Y; Katayama Y; Nakayama KI; Hatakeyama S
    J Cell Sci; 2010 Jul; 123(Pt 13):2238-45. PubMed ID: 20516148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
    Chandhoke AS; Chanda A; Karve K; Deng L; Bonni S
    Oncotarget; 2017 Mar; 8(13):21001-21014. PubMed ID: 28423498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
    Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
    Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Inhibitor of Activated STAT3 Regulates Migration, Invasion, and Activation of Fibroblast-like Synoviocytes in Rheumatoid Arthritis.
    Lao M; Shi M; Zou Y; Huang M; Ye Y; Qiu Q; Xiao Y; Zeng S; Liang L; Yang X; Xu H
    J Immunol; 2016 Jan; 196(2):596-606. PubMed ID: 26667168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.
    Jiao J; Zhang R; Li Z; Yin Y; Fang X; Ding X; Cai Y; Yang S; Mu H; Zong D; Chen Y; Zhang Y; Zou J; Shao J; Huang Z
    Nat Commun; 2018 Jun; 9(1):2504. PubMed ID: 29950561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIAS3 interacts with ATF1 and regulates the human ferritin H gene through an antioxidant-responsive element.
    Iwasaki K; Hailemariam K; Tsuji Y
    J Biol Chem; 2007 Aug; 282(31):22335-43. PubMed ID: 17565989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIAS3 may represent a potential biomarker for diagnosis and therapeutic of human colorectal cancer.
    Li H; Gao H; Bijukchhe SM; Wang Y; Li T
    Med Hypotheses; 2013 Dec; 81(6):1151-4. PubMed ID: 24120699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1.
    Nakagawa K; Yokosawa H
    FEBS Lett; 2002 Oct; 530(1-3):204-8. PubMed ID: 12387893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
    Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
    Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.
    Dabir S; Kluge A; Dowlati A
    Mol Cancer Res; 2009 Nov; 7(11):1854-60. PubMed ID: 19903771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation.
    Spoden GA; Mazurek S; Morandell D; Bacher N; Ausserlechner MJ; Jansen-Dürr P; Eigenbrodt E; Zwerschke W
    Int J Cancer; 2008 Jul; 123(2):312-321. PubMed ID: 18425820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential PIAS3 expression in human malignancy.
    Wang L; Banerjee S
    Oncol Rep; 2004 Jun; 11(6):1319-24. PubMed ID: 15138572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Super-resolution study of PIAS SUMO E3-ligases in hippocampal and cortical neurons.
    Conz A; Musi CA; Russo L; Borsello T; Colnaghi L
    Eur J Histochem; 2021 Aug; 65(s1):. PubMed ID: 34459572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription.
    Peng Y; Lee J; Zhu C; Sun Z
    J Biol Chem; 2010 Apr; 285(15):11465-75. PubMed ID: 20159969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of PIAS3 an inhibitor of activated STAT3 protein in human prostate cancer].
    Gan L; Yin ZF; Li M
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):419-21. PubMed ID: 18581899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitotic kinase Aurora-B is regulated by SUMO-2/3 conjugation/deconjugation during mitosis.
    Ban R; Nishida T; Urano T
    Genes Cells; 2011 Jun; 16(6):652-69. PubMed ID: 21554500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.